Login / Signup
Letter: interpretation of the BESST trial in the context of baseline antidepressant and neuromodulator use.
Brent Hiramoto
Walter Wai-Yip Chan
Published in:
Alimentary pharmacology & therapeutics (2023)
Keyphrases
</>
major depressive disorder
phase iii
study protocol
phase ii
clinical trial
open label
bipolar disorder